fig4

Figure 4. Correlation between the gene signature and prognosis in ccRCC patients. (A-C) Time-ROC curve analyses of the m6A score in all patients (A), the training set (B), and the validation set (C), respectively. (D-F) Kaplan-Meier survival curves of patients divided into low and high m6A score groups in all patients (D), the training set (E), and the validation set (F), respectively. ccRCC: Clear cell renal cell carcinoma; ROC: receiver operator characteristic curve.